Skip to content
Screener

Alkermes ALKS Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$55.8M+13.5%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$20.01M-14.1%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$22M-40.5%
LBR
LB Pharmaceuticals IncLBRX
$2.1M
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$231.56M+41.3%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.9%0.0pp

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.11B+85.1%
Enterprise value$9.18B+133%
P/E122.7×+110×
P/S4.9×+2.0×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemJune 30, 2026December 31, 2025
Total current assets1,522,9061,929,161
PROPERTY, PLANT AND EQUIPMENT, NET218,284221,722
INVESTMENTS—LONG-TERM35,054145
RIGHT-OF-USE ASSETS76,11177,209
INTANGIBLE ASSETS, NET1,761,456815
GOODWILL594,27383,027
DEFERRED TAX ASSETS123,041125,815
OTHER ASSETS62,00049,099

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's operating lease ROU assets?
Alkermes (ALKS) reported operating lease ROU assets of $76.11M in Q2 2026.
How has Alkermes's operating lease ROU assets changed year-over-year?
Alkermes's operating lease ROU assets decreased by 5.5% year-over-year, from $80.53M to $76.11M.
What is the long-term trend for Alkermes's operating lease ROU assets?
Over 5 years (2020 to 2025), Alkermes's operating lease ROU assets has grown at a -10.1% compound annual growth rate (CAGR), from $131.72M to $77.21M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Alkermes's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude